Glassman Wealth Services Fibrogen Inc Transaction History

Glassman Wealth Services

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.79 - $2.83 $82 - $294	104 New	104 $0
Q3 2021 Nov 10, 2021	SELL	$10.18 - $26.64 $81 - $213	-8 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$18.57 - $35.68 $148 - $285	8 New	8 $0
Q1 2020 May 12, 2020	SELL	$23.3 - $45.96 $302 - $597	-13 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$34.58 - $48.06 $172 - $240	5 Added 62.5%	13 $1,000
Q2 2019 Aug 08, 2019	SELL	$35.13 - $55.53 $281 - $444	-8 Reduced 50.0%	8 $0
Q1 2019 May 10, 2019	BUY	$42.83 - $59.91 $685 - $958	16 New	16 $1,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.